GlassScriptPhysician profile
Erin Draper
NPI 1598995201
$1,299.26
in general payments reported to CMS, 2019-2025
14 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $60.09 · 2021: $22.05 · 2022: $422 · 2023: $185 · 2024: $307 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $298.23 | 2022-2023 | Myday Contact Lens |
| Horizon Therapeutics Plc | $186.66 | 2020-2022 | |
| Abbvie INC. | $147.74 | 2022-2024 | |
| Alcon Vision LLC | $122.06 | 2024 | Total30, Precision 1, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $111.09 | 2019-2023 | Cequa |
| Amgen INC. | $92.04 | 2024 | Tepezza, Uplizna |
| Bausch & Lomb Americas INC. | $82.71 | 2025 | Infuse |
| Tarsus Pharmaceuticals, INC. | $72.80 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $51.89 | 2019 | |
| Glaukos Corporation | $40.91 | 2024 | Radius |
| Dompe US, INC. | $37.29 | 2025 | Oxervate |
| Genzyme Corporation | $22.05 | 2021 | |
| Spark Therapeutics, INC. | $17.18 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Draper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.